LeMaitre Vascular Inc. (NASDAQ:LMAT) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Friday. The firm currently has a $20.00 price target on the stock. Zacks Investment Research’s target price would indicate a potential upside of 16.28% from the stock’s […]
